UPDATE : Monday, December 16, 2019
‘Obesity treatment will drastically change next few years’ by Lee Han-soo 2019-12-04 18:20
'Insulin is safe, natural replacement therapy for diabetic patients' by Lee Han-soo 2019-12-04 17:07
SK Biopharm set to ensure superiority in antiepileptic drug by Jeong Sae-im 2019-12-04 16:18
Hanmi licenses in US firm’s oral immunotherapy candidate by Lee Han-soo 2019-12-04 16:16
ISU Abxis starts trial of Gaucher disease treatment in Australia by Lee Han-soo 2019-12-04 16:16
Korean patient with rare breast cancer to sue Allergan in US by Song Soo-youn 2019-12-04 14:49
Drugmakers strongly oppose post-approval evaluation by Kim Eun-young 2019-12-04 13:17
Swedish researchers divide Type 2 diabetes into 5 subgroups by Lee Han-soo 2019-12-03 17:45
Samyang Biopharm’s US subsidiary to work on new immunotherapy by Jeong Sae-im 2019-12-03 15:37
Technology developed to detect inflammatory disorders early by Song Soo-youn 2019-12-03 15:35
Ildong signs co-promotion contract with GSK Consumer Healthcare by Lee Han-soo 2019-12-03 15:18
Quick test for meningitis unavailable due to low reimbursement by Song Soo-youn 2019-12-03 13:24
Global diabetes group opens 5-day show in Busan by Lee Han-soo 2019-12-03 11:04
‘Obesity needs to be treated as a chronic disease’ by Lee Han-soo 2019-12-02 18:02
AMC develop treatment guideline lowering rectal cancer’s recurrence rate by Lee Han-soo 2019-12-02 16:46
‘Korea is lagging behind China in healthcare’ by Park Gi-taek 2019-12-02 15:26
Alteogen inks licensing-out deal for SC injection formulation technology by Jeong Sae-im 2019-12-02 15:25
LG Chem licenses in US firm’s diagnostic platform tech by Lee Han-soo 2019-12-02 13:42
[Special] Severe blood shortage keeps some hospitals from conducting surgeries by Kwak Sung-sun 2019-12-02 13:42
Syntekabio views industry’s crisis as opportunity by Jeong Sae-im 2019-11-29 17:54
Back to Top